Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals found liable in New York opioid trial
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva Pharmaceutical Industries Ltd. - Investors
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript
Teva Faces New Class Action—But Could It Afford Another Settlement? | Connecticut Law Tribune
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharma CEO Richard Francis on Q4 earnings
Teva Pharmaceutical | PBS NewsHour
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva expects lower profits in 2024 despite a strong Q4 performance | Ctech
Teva weighs potential sale of its $2B API business: reports
Teva's Q3 triumph: 7% revenue surge propelled by Austedo and Ajovy
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Pharmaceuticals (@TevaUSA) / X
Teva Pharmaceuticals reaches $4.3B deal in nationwide opioid settlement - YouTube
Watch Teva to Make Fewer Generic Drugs - Bloomberg
